Cargando…

Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is a rare clinical-radiological syndrome characterized by such symptoms as headaches, altered consciousness, blurred vision, seizure, and focal neurological deficits. We herein present well-documented PRES cases and discuss the risk fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Behnaz, Saadatnia, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781906/
https://www.ncbi.nlm.nih.gov/pubmed/35127580
http://dx.doi.org/10.4103/abr.abr_243_19
_version_ 1784638192903782400
author Ansari, Behnaz
Saadatnia, Mohammad
author_facet Ansari, Behnaz
Saadatnia, Mohammad
author_sort Ansari, Behnaz
collection PubMed
description BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is a rare clinical-radiological syndrome characterized by such symptoms as headaches, altered consciousness, blurred vision, seizure, and focal neurological deficits. We herein present well-documented PRES cases and discuss the risk factors and characteristic imaging patterns of this syndrome. MATERIALS AND METHODS: We prospectively examined 31 patients with PRES in Alzahra Hospital, Isfahan, Iran, and compared the underlying diseases of PRES in terms of their clinical features and cranial magnetic resonance imaging (MRI) findings. RESULTS: The most common underlying disease was hypertension (90.3%), followed by systemic lupus erythematosus (32.3%), preeclampsia (25.8%), chronic renal failure (22.6%), and rheumatoid arthritis (22.6%). Interestingly, we also reported heroin abuse as a possible risk factor for PRES (9.7%). The most frequent clinical signs were headaches (54.8%), seizure (54.8%), and blurred vision (35.5%). The most frequent lesions on cranial MRI were in the parieto-occipital area (87.1%), followed by the cerebellum (19.4%) and the frontal lobe (12.9%). Other abnormalities on MRI were less common. In addition, 16.1% of the study population had vasospasm on magnetic resonance arteriography (MRA). Clinical recovery was followed by radiological resolution in all the patients. CONCLUSIONS: The clinical presentation is nonspecific, most patients present with a combination of symptoms, particularly headaches and seizure. MRI is crucial for the diagnosis of PRES, and MRA is useful in that it can identify associated vasospasm. Timely diagnosis and treatment are required to avoid a devastating outcome.
format Online
Article
Text
id pubmed-8781906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87819062022-02-04 Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran Ansari, Behnaz Saadatnia, Mohammad Adv Biomed Res Original Article BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is a rare clinical-radiological syndrome characterized by such symptoms as headaches, altered consciousness, blurred vision, seizure, and focal neurological deficits. We herein present well-documented PRES cases and discuss the risk factors and characteristic imaging patterns of this syndrome. MATERIALS AND METHODS: We prospectively examined 31 patients with PRES in Alzahra Hospital, Isfahan, Iran, and compared the underlying diseases of PRES in terms of their clinical features and cranial magnetic resonance imaging (MRI) findings. RESULTS: The most common underlying disease was hypertension (90.3%), followed by systemic lupus erythematosus (32.3%), preeclampsia (25.8%), chronic renal failure (22.6%), and rheumatoid arthritis (22.6%). Interestingly, we also reported heroin abuse as a possible risk factor for PRES (9.7%). The most frequent clinical signs were headaches (54.8%), seizure (54.8%), and blurred vision (35.5%). The most frequent lesions on cranial MRI were in the parieto-occipital area (87.1%), followed by the cerebellum (19.4%) and the frontal lobe (12.9%). Other abnormalities on MRI were less common. In addition, 16.1% of the study population had vasospasm on magnetic resonance arteriography (MRA). Clinical recovery was followed by radiological resolution in all the patients. CONCLUSIONS: The clinical presentation is nonspecific, most patients present with a combination of symptoms, particularly headaches and seizure. MRI is crucial for the diagnosis of PRES, and MRA is useful in that it can identify associated vasospasm. Timely diagnosis and treatment are required to avoid a devastating outcome. Wolters Kluwer - Medknow 2021-12-25 /pmc/articles/PMC8781906/ /pubmed/35127580 http://dx.doi.org/10.4103/abr.abr_243_19 Text en Copyright: © 2021 Advanced Biomedical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ansari, Behnaz
Saadatnia, Mohammad
Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title_full Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title_fullStr Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title_full_unstemmed Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title_short Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran
title_sort prevalence and risk factors of posterior reversible encephalopathy syndrome in isfahan, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781906/
https://www.ncbi.nlm.nih.gov/pubmed/35127580
http://dx.doi.org/10.4103/abr.abr_243_19
work_keys_str_mv AT ansaribehnaz prevalenceandriskfactorsofposteriorreversibleencephalopathysyndromeinisfahaniran
AT saadatniamohammad prevalenceandriskfactorsofposteriorreversibleencephalopathysyndromeinisfahaniran